Cytek Biosciences (CTKB) Gross Margin (2020 - 2026)
Cytek Biosciences posted quarterly Gross Margin of 48.16% for Q1 2026, down 46.0% year-on-year from 89.18% in Q1 2025, and down 9.0% on a QoQ basis from 52.92% in Q4 2025.
Cytek Biosciences (CTKB) has 7 years of Gross Margin data on file, last reported at 48.16% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 46.0% year-over-year to 48.16%; the trailing twelve-month figure through Mar 2026 stood at 51.7% (down 324.0% YoY), and the FY2025 full-year result was 51.84%, down 358.0% from the prior year.
- Gross Margin for Q1 2026 stood at 48.16%, down from 52.92% in the prior quarter.
- Across five years, Gross Margin topped out at 66.36% in Q3 2022 and bottomed at 48.16% in Q1 2026.
- The 5-year median for Gross Margin is 56.62% (2023), against an average of 55.77%.
- The widest annual swing landed in 2022, when Gross Margin soared 8798 bps; it then slumped 974 bps in 2023.
- A 5-year view of Gross Margin shows it stood at 60.77% in 2022, then decreased by 7 bps to 56.75% in 2023, then increased by 3 bps to 58.55% in 2024, then retreated by 10 bps to 52.92% in 2025, then slipped by 9 bps to 48.16% in 2026.
- The last three Gross Margin figures came in at 48.16% (Q1 2026), 52.92% (Q4 2025), and 52.69% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | 48.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.16% |
| Dec 31, 2025 | 52.92% |
| Sep 30, 2025 | 52.69% |
| Jun 30, 2025 | 52.34% |
| Mar 31, 2025 | 48.62% |
| Dec 31, 2024 | 58.55% |
| Sep 30, 2024 | 56.32% |
| Jun 30, 2024 | 54.56% |
| Mar 31, 2024 | 51.30% |
| Dec 31, 2023 | 56.75% |
| Sep 30, 2023 | 56.62% |
| Jun 30, 2023 | 56.67% |
| Mar 31, 2023 | 56.72% |
| Dec 31, 2022 | 60.77% |
| Sep 30, 2022 | 66.36% |
| Jun 30, 2022 | 61.16% |
| Mar 31, 2022 | 57.54% |
| Dec 31, 2021 | -27.21% |
| Sep 30, 2021 | 61.89% |
| Jun 30, 2021 | 64.93% |
| Mar 31, 2021 | 59.68% |
| Dec 31, 2020 | -31.62% |
| Sep 30, 2020 | 62.23% |
| Jun 30, 2020 | 43.22% |